These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 32649342)
1. Mitotically Active Nevus and Nevoid Melanoma: A Clinicopathological and Molecular Study. Mesbah Ardakani N; Singh S; Thomas C; Van Vliet C; Harvey NT; Calonje JE; Wood BA Am J Dermatopathol; 2021 Mar; 43(3):182-190. PubMed ID: 32649342 [TBL] [Abstract][Full Text] [Related]
2. Fluorescence in situ hybridization for distinguishing nevoid melanomas from mitotically active nevi. Gerami P; Wass A; Mafee M; Fang Y; Pulitzer MP; Busam KJ Am J Surg Pathol; 2009 Dec; 33(12):1783-8. PubMed ID: 19809275 [TBL] [Abstract][Full Text] [Related]
3. Molecular Profiling of Noncoding Mutations Distinguishes Nevoid Melanomas From Mitotically Active Nevi in Pregnancy. Jackett LA; Colebatch AJ; Rawson RV; Ferguson PM; Thompson JF; McCarthy SW; Wilmott JS; Scolyer RA Am J Surg Pathol; 2020 Mar; 44(3):357-367. PubMed ID: 31743128 [TBL] [Abstract][Full Text] [Related]
4. A comparative study of proliferative nodules and lethal melanomas in congenital nevi from children. Yélamos O; Arva NC; Obregon R; Yazdan P; Wagner A; Guitart J; Gerami P Am J Surg Pathol; 2015 Mar; 39(3):405-15. PubMed ID: 25517953 [TBL] [Abstract][Full Text] [Related]
5. Molecular testing of borderline cutaneous melanocytic lesions: SNP array is more sensitive and specific than FISH. Carter MD; Durham AB; Miedema JR; Harms PW; Chan MP; Patel RM; Lowe L; Fullen DR; Hristov AC; Wang M; Andea AA Hum Pathol; 2019 Apr; 86():115-123. PubMed ID: 30576704 [TBL] [Abstract][Full Text] [Related]
6. Morphologic clues and utility of fluorescence in situ hybridization for the diagnosis of nevoid melanoma. Yélamos O; Busam KJ; Lee C; Meldi Sholl L; Amin SM; Merkel EA; Obregon R; Guitart J; Gerami P J Cutan Pathol; 2015 Nov; 42(11):796-806. PubMed ID: 26356543 [TBL] [Abstract][Full Text] [Related]
7. Loss of p16 expression and copy number changes of CDKN2A in a spectrum of spitzoid melanocytic lesions. Harms PW; Hocker TL; Zhao L; Chan MP; Andea AA; Wang M; Harms KL; Wang ML; Carskadon S; Palanisamy N; Fullen DR Hum Pathol; 2016 Dec; 58():152-160. PubMed ID: 27569296 [TBL] [Abstract][Full Text] [Related]
8. Maturing papillomatous nevoid melanoma in the scalp mimicking recurrent melanocytic nevus: A case report of previously undescribed subtype of nevoid melanoma. Tsujimura M; Kaku Y; Takeuchi Y; Ishida Y; Fujimoto M; Usui S; Yamada Y; Ogawa S; Shea CR; Haga H Pathol Int; 2022 Jan; 72(1):59-64. PubMed ID: 34637567 [TBL] [Abstract][Full Text] [Related]
9. p16 Range of expression in dermal predominant benign epithelioid and spindled nevi and melanoma. Oaxaca G; Billings SD; Ko JS J Cutan Pathol; 2020 Sep; 47(9):815-823. PubMed ID: 32330325 [TBL] [Abstract][Full Text] [Related]
10. Immunohistochemistry of p16 in nevi of pregnancy and nevoid melanomas: a clinical follow-up study. Koh SS; Lau SK; Roehmholdt BF; Cassarino DS J Clin Pathol; 2022 Jan; 75(1):68-70. PubMed ID: 33753560 [No Abstract] [Full Text] [Related]
11. PRAME and Historical Immunohistochemical Antibodies Ki-67, P16, and HMB-45 in Ambiguous Melanocytic Tumors. Mert M; Bozdogan O; Bozdogan N; Gamsızkan M; Safali M Am J Dermatopathol; 2024 Oct; 46(10):653-662. PubMed ID: 38916203 [TBL] [Abstract][Full Text] [Related]
12. Fluorescence in situ hybridization as a tool for microstaging in malignant melanoma. Newman MD; Lertsburapa T; Mirzabeigi M; Mafee M; Guitart J; Gerami P Mod Pathol; 2009 Aug; 22(8):989-95. PubMed ID: 19448594 [TBL] [Abstract][Full Text] [Related]
17. Mitotically active proliferative nodule arising in a giant congenital melanocytic nevus: a diagnostic pitfall. Nguyen TL; Theos A; Kelly DR; Busam K; Andea AA Am J Dermatopathol; 2013 Feb; 35(1):e16-21. PubMed ID: 23348144 [TBL] [Abstract][Full Text] [Related]
18. Deep penetrating nevus-like borderline tumors: A unique subset of ambiguous melanocytic tumors with malignant potential and normal cytogenetics. Magro CM; Abraham RM; Guo R; Li S; Wang X; Proper S; Crowson AN; Mihm M Eur J Dermatol; 2014; 24(5):594-602. PubMed ID: 25118781 [TBL] [Abstract][Full Text] [Related]
19. Fluorescence in situ hybridization for ambiguous melanocytic tumors. Gammon B; Gerami P Histol Histopathol; 2012 Dec; 27(12):1539-42. PubMed ID: 23059884 [TBL] [Abstract][Full Text] [Related]
20. Correlation between histologic assessment and fluorescence in situ hybridization using MelanoSITE in evaluation of histologically ambiguous melanocytic lesions. Zembowicz A; Yang SE; Kafanas A; Lyle SR Arch Pathol Lab Med; 2012 Dec; 136(12):1571-9. PubMed ID: 22480223 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]